Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 12 | 2018 | 637 | 2.020 |
Why?
|
| Positron-Emission Tomography | 10 | 2012 | 82 | 1.880 |
Why?
|
| Fluorodeoxyglucose F18 | 8 | 2012 | 33 | 1.600 |
Why?
|
| Spinal Cord Diseases | 2 | 2019 | 45 | 1.110 |
Why?
|
| Multimodal Imaging | 4 | 2012 | 23 | 0.940 |
Why?
|
| Coronary Artery Disease | 2 | 2023 | 126 | 0.870 |
Why?
|
| Sarcoma | 3 | 2011 | 65 | 0.760 |
Why?
|
| Bone Neoplasms | 3 | 2011 | 112 | 0.730 |
Why?
|
| Hernia | 1 | 2019 | 8 | 0.660 |
Why?
|
| Osteoblastoma | 1 | 2018 | 3 | 0.590 |
Why?
|
| Spinal Diseases | 1 | 2019 | 106 | 0.590 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2018 | 63 | 0.550 |
Why?
|
| Brain | 2 | 2023 | 1543 | 0.550 |
Why?
|
| Lung Neoplasms | 4 | 2011 | 544 | 0.540 |
Why?
|
| Arachnoid Cysts | 1 | 2016 | 4 | 0.530 |
Why?
|
| Spine | 2 | 2020 | 101 | 0.520 |
Why?
|
| Growth Plate | 1 | 2016 | 13 | 0.520 |
Why?
|
| Arabinonucleosides | 1 | 2016 | 3 | 0.510 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 268 | 0.510 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 10 | 0.510 |
Why?
|
| Back Pain | 1 | 2016 | 60 | 0.500 |
Why?
|
| Radiopharmaceuticals | 4 | 2015 | 46 | 0.480 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 150 | 0.460 |
Why?
|
| Humans | 24 | 2023 | 25165 | 0.440 |
Why?
|
| Postoperative Complications | 1 | 2019 | 841 | 0.430 |
Why?
|
| Myositis Ossificans | 1 | 2011 | 2 | 0.380 |
Why?
|
| Fluorine Radioisotopes | 1 | 2011 | 5 | 0.380 |
Why?
|
| Bronchial Diseases | 1 | 2011 | 1 | 0.370 |
Why?
|
| Pelvis | 1 | 2011 | 28 | 0.370 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2011 | 2 | 0.370 |
Why?
|
| Bronchial Neoplasms | 1 | 2011 | 5 | 0.370 |
Why?
|
| Radiation Injuries | 1 | 2011 | 28 | 0.370 |
Why?
|
| Fractures, Stress | 1 | 2011 | 20 | 0.370 |
Why?
|
| Aorta | 1 | 2011 | 15 | 0.360 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2011 | 10 | 0.360 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2011 | 30 | 0.350 |
Why?
|
| Lymph Nodes | 1 | 2011 | 70 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 1032 | 0.340 |
Why?
|
| Catheter Ablation | 1 | 2011 | 57 | 0.340 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 90 | 0.330 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 172 | 0.330 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 96 | 0.330 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 318 | 0.320 |
Why?
|
| Muscle Neoplasms | 1 | 2008 | 4 | 0.310 |
Why?
|
| Female | 12 | 2023 | 14161 | 0.290 |
Why?
|
| Neuroimaging | 2 | 2019 | 118 | 0.270 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 240 | 0.250 |
Why?
|
| Male | 10 | 2023 | 13815 | 0.250 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 24 | 0.220 |
Why?
|
| Head | 1 | 2023 | 21 | 0.220 |
Why?
|
| Whole Body Imaging | 3 | 2012 | 3 | 0.220 |
Why?
|
| Cerebral Veins | 1 | 2023 | 6 | 0.210 |
Why?
|
| Physical Examination | 1 | 2023 | 97 | 0.210 |
Why?
|
| Dyspnea | 1 | 2023 | 41 | 0.200 |
Why?
|
| Thrombosis | 1 | 2023 | 51 | 0.200 |
Why?
|
| Middle Aged | 8 | 2023 | 8303 | 0.200 |
Why?
|
| Adolescent | 2 | 2018 | 2018 | 0.190 |
Why?
|
| Blood | 1 | 2019 | 17 | 0.160 |
Why?
|
| Fibroma, Ossifying | 1 | 2018 | 5 | 0.150 |
Why?
|
| Osteoma | 1 | 2018 | 5 | 0.150 |
Why?
|
| Preoperative Period | 1 | 2018 | 68 | 0.140 |
Why?
|
| Paranasal Sinuses | 1 | 2018 | 62 | 0.140 |
Why?
|
| Aged | 3 | 2023 | 8448 | 0.140 |
Why?
|
| Syringomyelia | 1 | 2016 | 7 | 0.130 |
Why?
|
| Arachnoid | 1 | 2016 | 10 | 0.130 |
Why?
|
| Radionuclide Imaging | 1 | 2016 | 41 | 0.130 |
Why?
|
| Young Adult | 3 | 2018 | 1813 | 0.130 |
Why?
|
| Endoscopy | 1 | 2018 | 175 | 0.130 |
Why?
|
| Central Nervous System Cysts | 1 | 2015 | 5 | 0.120 |
Why?
|
| Sphenoid Sinus | 1 | 2015 | 13 | 0.120 |
Why?
|
| Technetium | 1 | 2015 | 4 | 0.120 |
Why?
|
| Adult | 5 | 2016 | 7259 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 78 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 442 | 0.110 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 71 | 0.110 |
Why?
|
| Chondrocalcinosis | 1 | 2012 | 3 | 0.100 |
Why?
|
| Sacroiliac Joint | 1 | 2011 | 9 | 0.090 |
Why?
|
| Joints | 1 | 2012 | 63 | 0.090 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2010 | 5 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 86 | 0.090 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2010 | 5 | 0.090 |
Why?
|
| Hemangiopericytoma | 1 | 2010 | 2 | 0.090 |
Why?
|
| Femoral Vein | 1 | 2009 | 2 | 0.080 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2009 | 4 | 0.080 |
Why?
|
| United States | 1 | 2016 | 1928 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2009 | 31 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 28 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 74 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 77 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 78 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3204 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 171 | 0.080 |
Why?
|
| Child | 1 | 2011 | 1211 | 0.070 |
Why?
|
| Infarction | 1 | 2023 | 28 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2020 | 35 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 66 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 119 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 7 | 0.030 |
Why?
|
| Rest | 1 | 2015 | 31 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2015 | 70 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 133 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 42 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 41 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 251 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2015 | 51 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 155 | 0.030 |
Why?
|
| Exercise Test | 1 | 2015 | 111 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 305 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 428 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 641 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2012 | 2 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2012 | 108 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1772 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 1672 | 0.020 |
Why?
|